Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, CanadaResearch in context

Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, CanadaResearch in context

Summary: Background: HCV infection is associated with mortality due to extrahepatic manifestations (EHM). Sustained virologic response (SVR) following direct-acting antiviral (DAA) therapy has been linked to decreased all-cause and liver-related mortality. However, evidence regarding the impact of...

Full description

Bibliographic Details
Main Authors: Dahn Jeong, Stanley Wong, Mohammad Ehsanul Karim, Amee R. Manges, Jean Damascene Makuza, Sofia R. Bartlett, Héctor Alexander Velásquez García, Daryl Luster, Prince Asumadu Adu, Mawuena Binka, Amanda Yu, Mel Krajden, Naveed Zafar Janjua
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:The Lancet Regional Health. Americas
Subjects:
Population-based study
HCV infection
Extrahepatic manifestations
Mortality
Direct-acting antivirals
Inverse probability of treatment weighting
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X23002326

Internet

http://www.sciencedirect.com/science/article/pii/S2667193X23002326

Similar Items